Robert Lafyatis
Impact in
- Pathology and Forensic Medicine top 0.05%
- Systemic Sclerosis and Related Diseases
- Rheumatology top 0.5%
- Rheumatoid Arthritis Research and Therapies
Papers in
-
- Systemic Sclerosis and Related Diseases 143
- Rheumatology 32
- Rheumatoid Arthritis Research and Therapies 23
- Co-authors
- Tracy Tabib (46 shared papers)Anita B. Roberts (14 shared papers)Michael B. Sporn (15 shared papers)Raphaël Lemaire (19 shared papers)Giuseppina Alessandra Farina (17 shared papers)Michael L. Whitfield (19 shared papers)Wei Chen (10 shared papers)Michael R. York (10 shared papers)
- Journals
- Journal of Investigative Dermatology (19 papers)Annals of the Rheumatic Diseases (16 papers)Arthritis & Rheumatology (14 papers)Lara D. Veeken (9 papers)Arthritis Research & Therapy (9 papers)
- Partner nations
- United StatesGermanyChina
In The Last Decade
Robert Lafyatis
260 papers receiving 21.6k citations
Robert Lafyatis's Hit Papers
Peers
Comparison fields: 5 of 136
- Pathology and Forensic Medicine 6k
- Rheumatology 1.7k
- Immunology 2k
- Infectious Diseases 1.7k
- Pulmonary and Respiratory Medicine 2.6k
Countries citing papers authored by Robert Lafyatis
This map shows the geographic impact of Robert Lafyatis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Lafyatis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Lafyatis more than expected).
Fields of papers citing papers by Robert Lafyatis
This network shows the impact of papers produced by Robert Lafyatis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Lafyatis. The network helps show where Robert Lafyatis may publish in the future.
Co-authors
The 25 scholars most cited alongside Robert Lafyatis, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 269 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | SARS-CoV-2 Receptor ACE2 Is an Interferon-Stimulated Gene in Human Airway Epithelial Cells and Is Detected in Specific Cell Subsets across Tissues Hit paper breakdown → | 2020 | 1828 |
| 2 | 1990 | 603 | |
| 3 | Proliferating SPP1/MERTK-expressing macrophages in idiopathic pulmonary fibrosis Hit paper breakdown → | 2019 | 594 |
| 4 | Safety and efficacy of subcutaneous tocilizumab in adults with systemic sclerosis (faSScinate): a phase 2, randomised, controlled trial Hit paper breakdown → | 2016 | 556 |
| 5 | Immune Landscape of Viral- and Carcinogen-Driven Head and Neck Cancer Hit paper breakdown → | 2020 | 527 |
| 6 | Shared and distinct mechanisms of fibrosis Hit paper breakdown → | 2019 | 507 |
| 7 | An integrated cell atlas of the lung in health and disease Hit paper breakdown → | 2023 | 471 |
| 8 | Adaptive plasticity of IL-10+ and IL-35+ Treg cells cooperatively promotes tumor T cell exhaustion Hit paper breakdown → | 2019 | 451 |
| 9 | Proteome-wide Analysis and CXCL4 as a Biomarker in Systemic Sclerosis Hit paper breakdown → | 2013 | 383 |
| 10 | 2007 | 371 | |
| 11 | 2010 | 342 | |
| 12 | 1991 | 335 | |
| 13 | Integrated Single-Cell Atlas of Endothelial Cells of the Human Lung Hit paper breakdown → | 2021 | 313 |
| 14 | 2019 | 307 | |
| 15 | Fresolimumab treatment decreases biomarkers and improves clinical symptoms in systemic sclerosis patients Hit paper breakdown → | 2015 | 302 |
| 16 | 1989 | 294 | |
| 17 | B cell signatures and tertiary lymphoid structures contribute to outcome in head and neck squamous cell carcinoma Hit paper breakdown → | 2021 | 287 |
| 18 | 2020 | 283 | |
| 19 | 2014 | 279 | |
| 20 | 2017 | 279 |
About Robert Lafyatis
Robert Lafyatis is a scholar working on Pathology and Forensic Medicine, Rheumatology, Pulmonary and Respiratory Medicine, Molecular Biology and Immunology, having authored 269 papers that have together received 22.1k indexed citations. Recurring topics across this work include Systemic Sclerosis and Related Diseases (143 papers), Rheumatoid Arthritis Research and Therapies (23 papers), TGF-β signaling in diseases (19 papers), Pulmonary Hypertension Research and Treatments (15 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (15 papers), Single-cell and spatial transcriptomics (15 papers), RNA Research and Splicing (8 papers) and Protease and Inhibitor Mechanisms (7 papers). The work is most often cited by research in Pathology and Forensic Medicine (6k citations), Rheumatology (1.7k citations), Immunology (2k citations), Infectious Diseases (1.7k citations) and Pulmonary and Respiratory Medicine (2.6k citations). Robert Lafyatis has collaborated with scholars based in United States, Germany and China. Frequent co-authors include Tracy Tabib, Anita B. Roberts, Michael B. Sporn, Raphaël Lemaire, Giuseppina Alessandra Farina, Michael L. Whitfield, Wei Chen, Michael R. York, Christina Morse and Elaine F. Remmers. Their work appears in journals such as Journal of Investigative Dermatology, Annals of the Rheumatic Diseases, Arthritis & Rheumatology, Lara D. Veeken and Arthritis Research & Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.